PROCEPT BioRobotics (PRCT) Cash from Investing Activities (QoQ) (2021 - 2026)
Analysis
PROCEPT BioRobotics (PRCT) Cash from Investing Activities (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.34% |
| Mar 31, 2026 | -57.51% |
| Dec 31, 2025 | 35.50% |
| Sep 30, 2025 | -2.36% |
| Jun 30, 2025 | -52.61% |
| Mar 31, 2025 | -56.39% |
| Dec 31, 2024 | -377.24% |
| Sep 30, 2024 | 76.41% |
| Jun 30, 2024 | 46.40% |
| Mar 31, 2024 | 77.67% |
| Dec 31, 2023 | -50.78% |
| Sep 30, 2023 | -7.59% |
| Jun 30, 2023 | -0.62% |
| Mar 31, 2023 | -516.51% |
| Dec 31, 2022 | 42.80% |
| Sep 30, 2022 | -594.50% |
| Jun 30, 2022 | -296.36% |
| Mar 31, 2022 | 83.43% |
| Dec 31, 2021 | -199.10% |
| Sep 30, 2021 | -0.91% |